Levonorgestrel/Ethinyl Estradiol
Sponsors
Wyeth is now a wholly owned subsidiary of Pfizer, University of Colorado, Denver, Incyte Corporation, Blueprint Medicines Corporation, AbbVie
Conditions
ContraceptionHealthyHealthy ParticipantsHealthy VolunteerHedonic FunctionMenstruation DisturbancesMoodNeural Activity
Phase 1
Study Comparing Two Manufacturing Processes for Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg (LNG/EE) in Healthy, Cycling Women
CompletedNCT00319163
Start: 2006-05-31End: 2006-11-30Target: 26Updated: 2009-08-07
Study Evaluating the Bioequivalence of Levonorgestrel/Ethinyl Estradiol Combinations in Cycling Women
WithdrawnNCT00447863
Start: 2007-08-31End: 2007-08-31Updated: 2021-08-20
A Study to Evaluate the Drug Interaction Between Povorcitinib and the Oral Contraceptive Levonorgestrel/Ethinyl Estradiol in Healthy Adult Females
CompletedNCT06380205
Start: 2024-05-07End: 2024-06-07Updated: 2024-07-03
A Study of Elenestinib in Healthy Adult Female Participants
CompletedNCT07388511
Start: 2026-02-05End: 2026-04-02Updated: 2026-04-20
A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives
CompletedNCT07414784
Start: 2026-02-11End: 2026-08-04Updated: 2026-08-31
Phase 3
Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder
CompletedNCT00128934
Start: 2005-08-31End: 2007-12-31Target: 744Updated: 2007-12-27
Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS
CompletedNCT00161681
Start: 2005-07-31End: 2006-08-31Target: 200Updated: 2013-02-08
Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder
CompletedNCT00195559
Start: 2005-09-30End: 2007-12-31Target: 526Updated: 2007-12-27